[Normoaldosterone spironolactone sensitive hypertension].
We report the case of normoaldosterone spironolactone sensitive hypertension. Patients suffering from this recently identified form of arterial hypertension exhibit clinical symptoms resembling the symptoms of primary aldosteronism. The described disturbances may be misdiagnosed as essential hypertension because plasma aldosterone levels and aldosterone/renin ratio in patients are within the normal ranges. In the described state of the examined female, detection of the disease and implementation of spironolactone treatment not only normalised arterial blood pressure but also allowed to avoid unnecessary administration of many antihypertensive agents.
Krysiak
Robert
R
Slaska Akademia Medyczna w Katowicach, Katedra Farmakologii, Zakład Farmakologii Klinicznej. r.krysiak@pharmanet.com.pl
Okopień
Bogusław
B
Herman
Zbigniew Stanisław
ZS
D000368:Aged; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D013148:Spironolactone / Q000627:therapeutic use*
D013148:Spironolactone